Physitrack Limited (PTRK) AI Stock Analysis

• Market Cap: kr240.66M
• Dividend Yield: N/A
• Average Volume (3M): 49.62K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.46
• Revenue Growth: -8.33%
• EPS Growth: -329.50%
• Country: SE
• Employees: 81
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.11
• Shares Outstanding: 16,260,765
• 10 Day Avg. Volume: 41,844
• 30 Day Avg. Volume: 49,617
• PEG Ratio: <0.01
• Price to Book (P/B): 0.62
• Price to Sales (P/S): 0.73
• P/FCF Ratio: -32.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: kr12.50 ▼(-7.06% Downside)

Physitrack Limited's overall stock score is primarily impacted by its financial performance, which shows significant challenges in revenue growth and profitability. Technical analysis indicates bearish momentum, further weighing down the score. Valuation concerns, highlighted by a negative P/E ratio and lack of dividend yield, also contribute to the low score.

Positive Factors

Business Model

The subscription-based model provides a stable and recurring revenue stream, enhancing predictability and financial planning over the long term.

Market Position

A strong market position in digital health and global reach supports sustained demand and potential for growth in the healthcare sector.

Balance Sheet Health

Low leverage indicates financial stability and flexibility, allowing the company to navigate economic fluctuations and invest in growth opportunities.

Negative Factors

Revenue Decline

Declining revenue growth suggests challenges in maintaining market momentum, which could impact long-term competitiveness and profitability.

Profitability Issues

Negative profitability margins highlight operational inefficiencies, which may hinder the company's ability to reinvest in growth and innovation.

Cash Flow Challenges

Negative free cash flow growth indicates difficulties in converting earnings into cash, potentially limiting investment capacity and financial resilience.

Physitrack Limited Business Overview & Revenue Model

Company Description

Physitrack PLC, together with its subsidiaries, operates as a digital healthcare provider worldwide. It offers SaaS platform, a cloud-based software platform used by single practitioners and large healthcare organizations, which enables the digitalization of the patient journey, from initial contact to patient interactions and outcomes tracking. The company also delivers virtual care in three distinct but related patient and insurance plan member need areas, such as prevention and wellness care, acute and chronic care, and surgical care. It offers its virtual care solutions to healthcare companies, including private and public hospitals, clinics, and other business owners. The company was formerly known as Physitrack Limited and changed its name to Physitrack PLC in May 2021. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.

How the Company Makes Money

Physitrack generates revenue through a subscription-based model, where healthcare providers pay for access to its platform and services. Key revenue streams include subscription fees from clinics and individual practitioners, as well as fees for additional features and services such as telehealth consultations and custom exercise program creation. The company may also generate revenue through partnerships with healthcare organizations, insurance companies, and educational institutions that integrate its solutions into their operations. Significant factors contributing to its earnings include the growing demand for digital health solutions and the increasing emphasis on remote patient management in the physiotherapy sector.

Physitrack Limited Financial Statement Overview

Summary

Physitrack Limited faces significant financial challenges, with declining revenue growth and negative profitability margins. While the balance sheet shows low leverage, the negative return on equity and cash flow issues indicate operational and financial inefficiencies.

Income Statement

Physitrack Limited shows a declining revenue growth rate of -2.83% in the TTM period, indicating challenges in maintaining revenue momentum. The company has negative net profit and EBIT margins, reflecting ongoing profitability issues. Despite a strong gross profit margin of 59.85% in the TTM, the negative EBIT and EBITDA margins highlight operational inefficiencies.

Balance Sheet

The company's debt-to-equity ratio of 0.22 in the TTM suggests a conservative leverage approach, which is a positive indicator of financial stability. However, the negative return on equity of -30.77% indicates that the company is not generating sufficient returns on shareholders' equity, which is a concern for investors.

Cash Flow

Physitrack Limited's free cash flow growth rate is significantly negative at -343.69% in the TTM, indicating cash flow challenges. The operating cash flow to net income ratio of 0.63 suggests that the company is generating cash flow, but the negative free cash flow to net income ratio highlights issues in translating earnings into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	15.18M	16.18M	15.18M	12.51M	7.81M	5.83M
Gross Profit	11.97M	16.18M	3.87M	12.37M	7.81M	5.83M
EBITDA	-2.23M	-2.09M	7.09M	2.57M	1.07M	1.60M
Net Income	-6.47M	-6.45M	3.20M	92.32K	-815.03K	688.41K
Balance Sheet
Total Assets	27.69M	30.51M	38.70M	41.31M	32.28M	11.95M
Cash, Cash Equivalents and Short-Term Investments	467.53K	723.39K	536.03K	577.74K	13.32M	775.55K
Total Debt	4.27M	4.81M	3.58M	831.66K	1.31K	1.97M
Total Liabilities	9.37M	11.34M	13.13M	18.94M	3.63M	6.76M
Stockholders Equity	18.32M	19.17M	25.57M	22.37M	23.29M	5.19M
Cash Flow
Free Cash Flow	598.04K	-363.54K	-773.78K	-3.04M	654.05K	1.05M
Operating Cash Flow	3.66M	3.13M	2.65M	1.45M	659.81K	2.03M
Investing Cash Flow	-3.09M	-3.49M	-5.04M	-14.78M	-4.54M	-773.58K
Financing Cash Flow	-670.57K	537.79K	2.34M	795.50K	14.85M	-3.37K

Physitrack Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 13.45
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:PTRK, the sentiment is Negative. The current price of 13.45 is below the 20-day moving average (MA) of 14.03, below the 50-day MA of 15.55, and below the 200-day MA of 14.82, indicating a bearish trend. The MACD of -0.71 indicates Negative momentum. The RSI at 40.98 is Neutral, neither overbought nor oversold. The STOCH value of 29.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:PTRK.

Physitrack Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KONT	52 Neutral	€70.86M	―	-3.01%	―	-3.31%	-240.00%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
PTRK	41 Neutral	kr240.66M	-3.26	―	―	-8.33%	-329.50%
QLINEA	40 Underperform	€478.92M	-0.27	-330.10%	―	270.64%	62.29%
ISOFOL	36 Underperform	€202.40M	―	-51.35%	―	―	-34.02%
ACTI	32 Underperform	€97.31M	-1.80	-1291.15%	―	―	28.54%
AINO	29 Underperform	€35.80M	―	-8607.90%	―	10.03%	66.78%